Illumina, the world’s largest DNA sequencing company announced the launch of thestartup named GRAIL to develop blood-based cancer tests.
- The company was launched in association with Microsoft co-founder Bill Gates, Amazon CEO Jeff Bezo’s venture fund Bezos Expeditions and Arch Venture Partners.
Key Highlights
- GRAIL will operate from San Diego in California, USA.
- The company will develop blood tests that cost $1000 or less for detecting many types of cancer before symptoms arise.
- The test, which is also called as liquid biopsy, will use high-speed DNA sequencing machines.
- All the partners in the startup raised around 100 million US dollars among themselves, in which Illumina will have the majority stake holder.
- The newly developed tests are expected to reach the market by 2019.
No comments:
Post a Comment